Delivery Order SPE2DB20D2104-SPE2DB23FS86Y

Award Date 3/31/23
Potential Completion Date 4/3/23
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $6,450.66 firm fixed-price contract is for the delivery of Aimovig 140 mg/mL autoinjector medication. The contract has an ultimate completion date of November 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,410.22 firm fixed-price contract is for the supply of 140 mg/mL Aimovig autoinjectors, a specialty medication. The contract has an ultimate completion date of September 21, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is valued at $2,380.50 and runs through January 13, 2025. It is for the provision of AIMOVIG 140 MG/ML AUTOINJECTORML, a specialty pharmaceutical product. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,623.42 firm fixed-price contract is for the supply of Aimovig 140 mg/ml autoinjectors, a medication used to prevent migraine headaches. The contract has an ultimate completion date of May 26, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,640.96, is for the delivery of AIMOVIG 70 MG/ML AUTOINJECTORML, a specialty medication. The contract has a firm fixed price pricing type and an ultimate completion date of August 17, 2022. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Aimovig 140 mg/ml autoinjector medication, with a ceiling value of $4,359.96 and a completion date of July 31, 2023. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen also holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation in the amount of $10,405.29. The order is for the pharmaceutical product Aimovig 70 mg/mL autoinjector. The contract has an ultimate completion date of August 20, 2024 and is a firm fixed price delivery order, with no set-aside designation. AmerisourceBergen, as a major pharmaceutical distributor, has been awarded numerous federal contracts and indefinite delivery vehicles to provide a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,504.58, is for the delivery of AIMOVIG 140 MG/ML autoinjectors. The award has a firm fixed price pricing type and an ultimate completion date of March 1, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under an existing Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract is for the supply of a specific pharmaceutical product, Aimovig 140 mg/ml autoinjector, with a ceiling value of $1,264.14 and a completion date of February 27, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation indicated. As a key...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,641.20, is for the delivery of the medication Aimovig 140 mg/ml autoinjector. The contract is a firm fixed-price delivery order, with an ultimate completion date of March 15, 2023. It is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp is a...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB23FS86Y
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,587.20, is for the delivery of the medication Aimovig 140 mg/ml autoinjector. The contract has a firm fixed price pricing type and an ultimate completion date of April 3, 2023. The contract is not designated with a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000, covering similar medical products and prescription drugs.

Generated 2/27/25, 11:15 AM